Visalytics
Visalytics
approved EB-1A RFE Issued

PhD Candidate

Biomaterials · Iran · 2025-11-14

Processing Time
111 days
Decision Date
2025-11-14
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Scholarly Articles (Met)

The petitioner published 13 peer-reviewed articles and 1 preprint in elite venues within the field of biomaterials.

Judging (Met)

The petitioner completed 16 peer reviews for distinguished journals, demonstrating recognition as an expert who judges the work of others.

Original Contributions (Met)

The petitioner's research in hydrogels and nanotechnology garnered 722 citations, placing him in the top 1% of authors and showing major significance to the field.

Why This Petition Was Approved

The approval was based on 13 peer-reviewed journal articles and 722 citations, placing the petitioner in the top 1% of cited authors. Additionally, the petitioner completed 16 peer reviews for distinguished journals and received funding from prestigious organizations like the NIH and NSF. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging roles.

Request for Evidence (RFE)

Successfully Addressed

A Request for Evidence was issued during the 3 month and 21 day processing period. The firm successfully responded to the RFE by highlighting the client's groundbreaking research and prestigious funding, resulting in approval.

RFE Targets
Original ContributionsScholarly Articles

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Evidence Submitted
  • 13 peer-reviewed journal articles (6 first-authored)
  • 1 preprint publication
  • 722 citations (top 1% most highly cited authors)
  • 16 peer reviews for distinguished journals
  • Research in dynamic hydrogels for cell-material interactions
  • Research in nanotechnology for wound healing
  • Research in biomaterials for drug delivery systems

Similar Cases

Research Assistant

Materials Science · China

WeGreened EB-1A approved
New Mexico 342 days 2025-03-12
The petition was approved based on 16 peer-reviewed articles, one preprint, and two book chapters which garnered 361 citations. The petitioner also demonstrated expertise through 28 peer reviews for academic journals and original contributions to drug delivery and wastewater treatment. Additionally, the research was validated by funding from the National Natural Science Foundation of China and unsolicited conference speaking invitations.
View Case

Lecturer

Biotechnology · China

WeGreened EB-1A rfe approved
112 days 2025-04-21
The petition was approved based on 12 peer-reviewed journal articles and a high citation count of 2,446. Additionally, the petitioner completed 30 peer reviews and secured funding from the National Natural Science Foundation of China (NSFC), satisfying the EB-1A criteria for scholarly articles, judging, and original contributions.
View Case

Postdoctoral Researcher

Research and Development · Turkey

WeGreened EB-1A approved
Ohio 15 days 2025-07-22
The petition was approved based on 18 peer-reviewed journal articles (13 as first author) and 663 citations, with three papers in the top 10% of the field. Evidence also included 14 manuscript reviews for high-impact journals like Applied Catalysis B: Environmental. These metrics satisfied the EB-1A criteria for scholarly articles, judging, and original contributions of major significance.
View Case

Scientist

Biotechnology · India

WeGreened EB-1A approved
Illinois 37 days 2025-06-12
The petition was approved based on meeting at least three EB-1A criteria: scholarly articles, original contributions of major significance, and judging the work of others. Metrics included 13 peer-reviewed journal articles, 388 citations, and 30 instances of peer review for prestigious journals. The case was further strengthened by evidence of substantial research funding from the NIH, NSF, and U.S. Department of Energy.
View Case

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-11-14.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 111 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-1A Case Data

Scraped Case Data

Total Cases 883
Success Rate 52.8%
Sustained 466
Dismissed 300

Related Pages

EB-1A Overview EB-1A in Iran All EB-1A Cases EB-1A Dashboard

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist